Congress has zero serious momentum on psychedelics right now, and politicians don't want to take a risky vote on a still-controversial topic in an election year. Without FDA approval as political cover, most lawmakers won't touch a standalone psychedelic bill.
The docket shows zero psychedelic legislative momentum. Election-year caution and lack of FDA approval keep members from standalone votes.